Rallyday invests in Genesis Research

Rallyday Partners has made an investment in Hoboken, New Jersey-based Genesis Research LLC, a data analytics and research partner for the life science industry.

Rallyday Partners has made an investment in Hoboken, New Jersey-based Genesis Research LLC, a data analytics and research partner for the life science industry. No financial terms were disclosed.


Rallyday Partners (Rallyday), a Denver-based private equity firm, announced today that it has made a significant growth investment into Genesis Research LLC (Genesis or the Company), a global provider of Real World Evidence (RWE) services and Health Economics and Outcomes Research (HEOR) to the health and life sciences industries.

Headquartered in Hoboken, NJ, Genesis Research is dedicated to providing end-to-end strategy, evidence generation, and communication services which include data governance, quantitative RWE generation, biostatistics, digital platforms, scientific communications, pricing, market access, and HEOR to the life sciences industry.

“We can’t imagine finding better partners than Steve Arikian, Frank Corvino, and their entire team,” said Mark Hopkins, Co-Founder and Managing Partner with Rallyday. “They have built a magical business and our investment will allow Genesis to expand their service offering and geographic reach. We are truly honored and thrilled to support this elite team’s vision.”

With over 100 recent RWE publications, Genesis Research is a well-respected, trusted provider that has been serving manufacturers of novel medical technologies in oncology, central nervous system (CNS), Immunology, Inflammation and many other therapeutic areas since its founding in 2009. The Company’s research and novel client engagement allow life sciences companies to better understand and articulate their products’ value. Genesis Research’s work leads to better clinical outcomes, improved quality of life for patients, and ultimately lower costs for payers, patients, and the overall healthcare system.

“As one of the fastest-growing RWE-centric companies in our industry, we are excited to partner with Rallyday in this next stage of the firm’s growth,” said Frank A. Corvino, Chief Executive Officer and Co-Founder of Genesis Research. “We will continue, as always, to deliver service excellence to our clients, and this new chapter will enable us to maintain our culture as we grow, enhance our existing capabilities, and expand into new services and geographies.”

Steve Arikian, Chairman and Co-Founder of Genesis Research, added, “We chose Rallyday, among many potential partners, because of our shared values and their impressive experience building and scaling successful businesses first-hand as CEOs. Together we will build the leading Value Demonstration Company by expanding our services through continued organic growth and acquisitions.”

About Genesis Research:
Genesis Research is a data analytics and research partner to the Life Sciences industry delivering real world evidence services to satisfy regulatory, payer, and commercial requirements throughout the product lifecycle. As a leader in evidence development and communication, Genesis Research also supports clients with unique services such as rapid response analytics, outcomes simulation, and payer data collaboration. For more information about Genesis Research, please visit http://www.GenesisRG.com.

About Rallyday Partners:
Rallyday Partners, headquartered in Denver, Colorado, is a private equity firm investing growth capital in founder-led companies in the healthcare, education and IT services industries. For more information about Rallyday, please visit http://www.rallydaypartners.com.